Case Study: a drug-focused organization accelerates combination product readiness with Kymanox

A Kymanox Case Study

Drug Product Expansion into Combination Product- Case Study

The customer, a drug-focused organization, faced the challenge of expanding its portfolio from drug-only to combination products. It needed a clear pathway to clinical readiness, a risk-based approach to streamline verification, and to optimize its Design History File (DHF) to meet regulatory expectations without redundant activities. They engaged Kymanox for its expertise in combination product strategy and product development.

Kymanox developed a platform approach for device development and DHF documentation, enabling the efficient reuse of design elements and verification activities across product variants. The solution provided detailed regulatory education and comprehensive answers to over ten technical inquiries. This established a scalable framework that accelerated the client's time-to-clinic, reduced future development timelines, and enabled an efficient transition into combination product development.


View this case study…

Kymanox

58 Case Studies